Navigation Links
CryoLife to Participate in Lazard Capital Markets 9th Annual Healthcare Conference
Date:11/6/2012

ATLANTA, Nov. 6, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that Steven G. Anderson, president and chief executive officer of CryoLife, Inc., is scheduled to present in the upcoming Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at 3:00 pm ET in New York City. 

CryoLife's live presentation may be accessed through its Web site, www.cryolife.com, on the Investor Relations page.  An archived copy of the presentation will be available for 90 days on the same Web site.

About CryoLifeFounded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the U.S., certain countries in Europe, and Canada.  CryoLife's CryoValve® SG pulmonary heart valve, processed using CryoLife's proprietary SynerGraft® technology, has FDA 510(k) clearance for the replacement of diseased, damaged, malformed, or malfunctioning native or prosthetic pulmonary valves.  CryoLife's CryoPatch® SG pulmonary cardiac patch has FDA 510(k) clearance for the repair or reconstruction of congenital heart defects.  CryoLife's BioGlue® Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels.  BioGlue is also CE marked in the European Community for use in soft tissue repair and is approved in Japan for use in the repair of aortic dissections.  Additional marketing approvals for BioGlue have been granted in several other countries throughout the world.  CryoLife, through its subsidiary Cardiogenesis Corporation, specializes in the treatment of coronary artery disease for severe angina using a laser console system and single use, fiber-optic handpieces to perform a surgical procedure known as Transmyocardial Revascularization (TMR).  In addition, CryoLife's subsidiary Hemosphere, Inc. markets the HeRO® Graft, which is a solution for end-stage renal disease in certain hemodialysis patients.  CryoLife distributes PerClot®, an absorbable powder hemostat, in the European Community and other select international countries.  CryoLife's BioFoam Surgical Matrix is CE marked in the European Community for use as an adjunct in the sealing of abdominal parenchymal tissues (liver and spleen) when cessation of bleeding by ligature or other conventional methods is ineffective or impractical. 

For additional information about the company, visit CryoLife's website:
http://www.cryolife.com.

Contacts:CryoLifeThe Ruth GroupD. Ashley Lee

Nick Laudico / Zack KubowExecutive Vice President, Chief Financial Officer

646-536-7030 / 7020and Chief Operating Officer

nlaudico@theruthgroup.comPhone: 770-419-3355

zkubow@theruthgroup.com


'/>"/>
SOURCE CryoLife, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
2. CryoLife Completes Acquisition of Hemosphere
3. CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference
4. CryoLife Announces Release Date and Teleconference Call Details for 2012 Second Quarter Financial Results
5. CryoLife Reports 13% Revenue Growth for Second Quarter 2012
6. CryoLife Announces Initiation of Quarterly Cash Dividend
7. CryoLife Reports 13% Revenue Growth for Third Quarter 2012
8. WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day
9. Hill-Rom to Participate in the Deutsche Bank Securities Health Care Conference
10. Hill-Rom to Participate in the Bank of America Merrill Lynch 2012 Health Care Conference
11. University of Michigans Wolverine Venture Fund Participates in $25 Million Series D Investment in Sonitus Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, ... company active in the biopharmaceutical, nutraceutical, and aquacultural ... development of its lead drug candidates, AGR131.  This ... proinflammatory cytokine from the blood of patients suffering ... and inflammatory bowel disease. ...
(Date:8/2/2017)... 2, 2017  Life Flight Network and PeaceHealth Oregon Network ... patient care and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, ... and Life Flight Network work collaboratively to move patients who ... when a time sensitive emergency exists. ...
(Date:7/31/2017)... , July 31, 2017 Three Tru-D SmartUVC robots ... South Korea . Tru-D, short for "Total Room Ultraviolet Disinfection," ... rooms after an environmental services (ES) professional cleans the area with traditional ... Tru-D ... "Although the BAACH has ...
Breaking Medicine Technology:
(Date:8/16/2017)... Long Island, NY (PRWEB) , ... August 16, 2017 , ... ... assist with IV starts and blood draws. By broadly deploying AccuVein devices, Maury Regional ... technology takes much of the guesswork out of a needle stick and more importantly, ...
(Date:8/16/2017)... ... August 16, 2017 , ... LabRoots , the leading ... around the world, is excited to announce Andrew Ly as the winner of the ... covering textbook costs. , Ly, who is in his third year at the ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... Endoscopes states: “Drying the endoscope after every reprocessing cycle, both between patient procedures ... transmission and nosocomial infections. Drying is as important to the prevention of disease ...
(Date:8/16/2017)... ... August 16, 2017 , ... Harbor Retirement Associates ... announced today that two of their associates were recognized with individual “Best of ... living communities in Florida. The awards were announced at the 5th Annual 2017 ...
(Date:8/16/2017)... ... ... TopConsumerReviews.com recently gave a best-in-class 5 star rating to Test Country, a leader ... States has undergone major changes over the last decade, particularly when it comes to ... get a blood test or other lab work done. Today, most tests are available ...
Breaking Medicine News(10 mins):